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Abstract: Solid platelet-rich fibrin (PRF) is produced with centrifugation tubes designed to accelerate
clotting. Thus, activated platelets may accumulate within the fibrin-rich extracellular matrix even
before centrifugation is initiated. It can thus be assumed that platelets and their growth factors such as
transforming growth factor-β (TGF-β) are trapped within PRF independent of their relative centrifugal
force (RCF), the gravitation or g-force. To test this assumption, we prepared PRF membranes with
tubes where clotting is activated by a silicone-coated interior. Tubes underwent 210 g, 650 g and 1500 g
for 12 min in a horizontal centrifuge. The respective PRF membranes, either in total or separated
into a platelet-poor plasma and buffy coat fraction, were subjected to repeated freeze-thawing to
prepare lysates. Gingival fibroblasts were exposed to the PRF lysates to provoke the expression of
TGF-β target genes. We show here that the expression of interleukin 11 (IL11) and NADPH oxidase 4
(NOX4), and Smad2/3 signaling were similarly activated by all lysates when normalized to the size of
the PRF membranes. Notably, platelet-poor plasma had significantly less TGF-β activity than the
buffy coat fraction at both high-speed protocols. In contrast to our original assumption, the TGF-β
activity in PRF lysates produced using horizontal centrifugation follows a gradient with increasing
concentration from the platelet-poor plasma towards the buffy coat layer.
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1. Introduction
Platelet-rich fibrin is produced by the centrifugation of venous blood that undergoes coagulation [1].
Platelet-rich fibrin (PRF) can then be used in various clinical indications, including ridge preservation
after tooth extraction [2], to increase the width of keratinized mucosa around implants [3], or to
prepare sticky bone prior to augmentation [4], as summarized recently [5]. PRF is also applied to
support the healing of hard-to-heal ulcers [6]. However, coagulation of PRF within tubes is usually
not spontaneously being enhanced by clotting activators. Unlike glass tubes, plastic tubes do not
support rapid clotting; thus, plastic clot activator tubes usually contain siliceous substances and
polyvinylpyrrolidone-like compounds to enhance the adherence and to facilitate rapid dissolution of
silica into collected blood. PRF prepared by plastic tubes consequently accumulates the clot activators
favoring faster clotting [7]. Rapid clotting and thus the impact of the clot activators was recently
proposed to amend the current “gradient” theory of platelet distribution based on centrifugation
protocols [8].
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Previous findings [8] have started a debate about the various centrifugation protocols and their
impact on the quality of the PRF, a quality that was mainly defined by the release of growth factors [9–11]
and by provoking gene expression changes [12]. Centrifugation protocols were originally refined
with the goal of an equal distribution and accumulation of platelets within the platelet-poor plasma
and the buffy coat layer moving from the original L-PRF protocol (700 g, 12 min) towards a slower
A-PRF protocol (210 g, 8–12 min) in fixed-angle centrifuges [9]. Recently, horizontal centrifugation
was introduced, allowing a faster and sharper separation of the cells according to their density in
H-PRF [13]. The impact of gravitation force (g-force) and time on the gradient of platelets and leucocytes
in the tubes was measured in anticoagulated blood [14,15]. The impact of the clot activators was not
considered here.
Blood coagulation is a rapid process that initiates during the blood draw and centrifugation
process [16]. Coagulation is enhanced by the addition of a clot activator, such as silica. Activated
clotting time is usually around 2 min [17]; thus, the coagulation is rapidly advancing even before the
tubes are exposed to centrifugation forces. Usually, the recommended time between the blood drawing
and start of centrifugation is 60–90 s; otherwise the size of the PRF membrane is negatively affected [18].
Noteworthy, it is not only the size of the PRF membrane that matters but attention has also been paid
to the distribution of platelets within the PRF membranes [8], as platelets are rapidly activated during
the coagulation cascade and thereby entrapped in the developing fibrin-rich extracellular matrix.
Moreover, platelets release the content of their granules within a few seconds [19]. Considering that
the fibrin-rich extracellular matrix can adsorb at least part of the growth factors from the granules, it is
possible that their distribution in PRF is not significantly affected by various centrifugation protocols.
Transforming growth factor-β (TGF-β) is stored in the alpha granules of platelets and immediately
released upon activation of the coagulation cascade [19]. TGF-β can then adsorb to the heparin-binding
domain of fibrin (ogen) [20]. Thus, in blood collection tubes of accelerated clotting, it is possible that
TGF-β adsorbs to the developing blood clot even before centrifugation is initiated and continues
thereafter. Fibronectin [21] and vitronectin [22], both being part of the blood clot [23], bind TGF-β.
In support of these molecular principles, immunostainings of PRF revealed that TGF-β1 is present
throughout the matrix, with an accumulation on the distal surface from PRF clots produced using
fixed-angle centrifuges [24], refining studies on the release of TGF-β into the supernatant of PRF [9,10].
Taken together, it might be hypothesized that not only the total TGF-β activity in the PRF membranes,
but also the distribution of TGF-β, are hardly affected by the centrifugation protocol.
Considering that it is usually the entire PRF membrane, independent of the centrifugation protocol
that is used in a clinical setting, the amount of TGF-β released from the PRF membranes is typically
detected by immunoassays. It was only recently that the TGF-β activity in liquid PRF was determined
by a bioassay [25]. Moreover, no attempts have previously been made to investigate the distribution of
TGF-β activity inside the PRF membranes following various centrifugation protocols. Also, the TGF-β
activity released upon fibrinolysis by plasmin (EC 3.4.21.7) has not been investigated so far [26].
Therefore, the aim of the present study was to compare the TGF-β activity in the lysates of PRF
membranes produced by horizontal centrifugation using tubes with clot activators at different g-forces.
We report here that the total TGF-β activity is similar among the PRF membranes produced using
different protocols; however, despite the proposed binding of TGF-β to the fibrin-rich matrix, there is a
clear gradient of TGF-β activity within the PRF membrane towards the buffy coat produced at higher
centrifugation speeds.
2. Results
2.1. PRF Lysates Prepared at 210 g, 650 g and 1500 g Provoked an Equal Increase of TGF-β Target Genes
To evaluate the effect of different g-forces on activation of TGF-β signaling, oral fibroblast cells
were exposed to 30% of the PRF lysates prepared at different g-forces but normalized to the length of
the PRF membrane (Table 1). Analysis of gene expression changes revealed that IL11 and NOX4 genes
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were upregulated in the presence of all variants of PRF lysates. Statistical analysis showed that the
same increase of IL11 and NOX4 expression is achieved by 210 g, 650 g and 1500 g (p = 0.35, p = 0.27,
respectively; Figure 1). These observations suggest that PRF lysates produced upon freeze-thawing
and sonication, when normalized to the original length of the PRF membrane, can activate the TGF-β
signaling pathway regardless of the g-force applied.
Table 1. The size of platelet-rich fibrin (PRF) membranes prepared at different g-forces are listed below
in cm.
210 g (cm) 650 g (cm) 1500 g (cm)
Donor 1 1.5 3.0 4.0
Donor 2 2.0 2.5 3.5
Donor 3 2.0 3.0 4.0
Donor 4 2.0 3.0 3.5
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To confirm the findings obtained by gene expression analysis, we measured the levels of IL11 
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transcripts, all the normalized PRF lysates prepared at 210 g, 650 g and 1500 g had a substantial impact 
on the production of IL11 by gingival fibroblasts on the protein level compared to unstimulated 
controls (Figure 2). Importantly, the amount of IL11 production was strongly induced by all PRF 
protocols (all p < 0.001), but independent of the centrifugation protocol used to prepare the PRF 
membranes (all p-values around 0.9) 













Figure 1. PRF lysates prepared at 210 g, 650 g and 1500 g provoked a robust increase of TGF-β target
genes. Gingival fibroblast cells were exposed to 30% of PRF lysates prepared at different g-forces
(210, 650 and 1500 g). Analysis of gene expression changes revealed that IL11 (A) and NOX4 (B) genes
were upregulated in the presence of all variants of PRF lysates. Statistical analysis showed no significant
differences (p > 0.05) between different variants of PRF lysates. These observations suggest that PRF
lysates can activate the transforming growth factor-β (TGF-β) signaling pathway, regardless of the
g-force applied. Statistical analysis was based on an ANOVA (n = 3).
2.2. PRF Lysates Prepared at 210 g, 650 g and 1500 g Caused an Equal Production of IL11 Protein
To confirm the findings obtained by gene expression analysis, we measured the levels of IL11
protein in the supernatant of gingival fibroblasts. In agreement with the strong increase of IL11
transcripts, all the normalized PRF lysates prepared at 210 g, 650 g and 1500 g had a substantial impact
on the production of IL11 by gingival fibroblasts on the protein level compared to unstimulated controls
(Figure 2). Importantly, the amount of IL11 production was strongly induced by all PRF protocols
(all p < 0.001), but independent of the centrifugation protocol used to prepare the PRF membranes
(all p-values around 0.9).
2.3. Expression Changes Were Blocked in the Presence of the TGF-β Receptor Type I Kinase Inhibitor
To confirm the involvement of TGF-β signaling to regulate the respective genes, the TGF-β
receptor 1 inhibitor SB431542 (10 µM) was applied. We report here that SB431542 blocked the activity
of PRF lysates prepared at 210 g, 650 g and 1500 g to increase the expression of IL11 and NOX4.
These observations support the notion that the effects of the PRF lysates prepared at 210 g, 650 g and
1500 g are similarly mediated via the TGF-β receptor (Figure 3).
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Figure 2. PRF lysates prepared at 210 g, 650 g and 1500 g accumulate IL11 in the cell supernatant.
Gingival fibroblasts were exposed to 30% of PRF lysates prepared at 210 g, 650 g and 1500 g. The levels
of IL11 in the supernatant of the fibroblasts are presented in ng/mL. Bar graphs show the means and
standard deviation of four independent experiments. Statistical analysis was based on an ANOVA.
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Figure 3. Expression changes were blocked in the presence of the TGF-β receptor type I kinase inhibitor.
Gingival fibroblasts were exposed to 30% of PRF lysates prepared at different g-forces with and without
the TGF-β receptor 1 antagonist SB431542. Expression analysis of (A) IL11 and (B) NOX4 is expressed
as x-fold increases c mpared to the basal levels of untreated cells. Bar graphs show the means and
stand rd deviation of three independ nt experiments. Bar graphs show t e means and standard
devi tion of three independ nt experiments. Statistical analysis was ba ed on paired t-test.
2.4. PRF Lysates Prepared at 210 g, 650 g and 1500 g Provoked an Equal Activation of Smad2/3 Signaling
In support of the activation of TGF-β receptor signaling [27], immunofluorescence and Western
blot analysis were performed. Consistent with the proposed TGF-β activity, all variations of PRF
lysates prepared at 210 g, 650 g and 1500 g provoked the nuclear translocation of Smad2/3 in gingival
fibroblasts. Again, the magnitude of nuclear translocation of Smad2/3 was visibly similar among the
three PRF protocols (Figure 4). Considering that phosphorylation of S ad3 is a prerequisite for its
nuclear translocation, we showed that consistently all three separate protocols of PRF could provoke
an i creased phosphorylation of Smad3, and more i rta tl , it t e sa e agnitude (Figure 5).
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Gingival fibroblasts ere exposed for 1 h to 30% of the PRF lysates prepared at different g-forces.
Immunofluorescence revealed the nuclear translocation of Smad2/3 by all variants of PRF lysates
compared to the untreated control. Scale bars are 100 µm. The Figure is representative for three
independent experiments.
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blood cell layer, representing th buffy coat (BC), and the upper lay r was term d platelet-poor plasma
(PPP). Gingival fibroblasts were exposed to 30% lysate of PPP or the BC fraction followed by IL11 and
NOX4 gene expression analysis. The BC fractio of the PRF m mbranes produced at 1500 g and 650 g
demonstrated a si nificantly better capacity to increase IL11 and NOX4 expression than the respective
PPP fractions (Figure 6A,B). Noteworthy, the TGF-β activity was completely lacking in the PPP layer
when pr pared using the 1500 g protocol. Immunoassay confirmed that the am unt of active TGF-β1
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plasma (PPP) in PRF 1500 g and 650 g. Gin ival fibroblasts were exposed to 30% of lysates from PPP
and BC layers of prepared at 650 g and 1500 g. Analysis of gene expression changes r vealed that
IL11 (A) was upregulat d significantly i the BC layer of PRF prepared at 1500 g and 650 g, and the
NOX4 (B) gene was upregulated i the presence of all variants of PRF lysates. Statistical analysis
showed no signific nt differenc s (p > 0.05) between the PPP d BC layers in NOX4 gene expression.
T ese observations suggest that the BC layer has more TGF-β activity compared to the upp rmost PPP
lay r (n = 6). Concentration of ctiv TGF-β in t e BC and PPP fr ons of PRF prepared at 1500 g and
650 g was evaluated by immunoass y (C). Data represent the mean and standard deviation. TGF-β is
indicated in pg/mL. Statistical analysis wa conducted using ANOVA (n = 6).
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Figure 7. The plasmin-digested PPP fraction at 1500 g did not increase TGF-β target genes expression.
Gingival fibroblasts were exposed to 30% of the BC and PPP fraction of PRF lysates prepared at 1500 g
and the plasmin-digested PPP fraction. Gene expression analysis indicated that plasmin digestion is
not sufficient for PPP to make changes in the expression of IL11 (A) and NOX4 (B). Data represent the
mean and standard deviation of three independent experiments. Statistical analysis was performed
using ANOVA (n = 3).
2.6. PPP Lysates Prepared at 1500 g Failed to Considerably Activate Phosphorylation of Smad3
In support of the activation of TGF-β receptor signaling mainly by BC and not PPP, phosphorylation
of Smad3 was evaluated. Gingival fibroblasts were exposed to 30% of the BC and PPP fractions of
PRF lysates prepared at 650 g and 1500 g for 16 h. Western blot indicated that BC fractions of PRF
lysates prepared at 650 g and 1500 g provoked an increased phosphorylation of Smad3. In contrast,
PPP fractions failed to generate a similar response (Figure 8).
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3. Discussion
The present research is based on the concept that clot activator blood collection tubes
simultaneously activate platelets and kick-start the formation of a fibrin-rich extracellular matrix.
TGF-β, being rapidly released from platelets, is then bonded to the fibrin-rich extracellular matrix and
thereby escapes from the g-force produced by the centrifugation forces. Thus, when using the clot
activator blood collection tubes, the TGF-β activity in the PRF membranes is theoretically independent
of g-force. We report here that the TGF-β activity of normalized PRF lysates produced at 210 g,
650 g and 1500 g for 12 min in a horizontal centrifuge is indeed rather similar. Considering that the
size of the PRF membranes increases with increasing g-forces, the total TGF-β activity also has the
potential to increase. With increasing g-forces, however, the PPP fraction gradually loses its TGF-β
activity. This finding is important because it shows that even in clot activator blood collection tubes,
the TGF-β activity in PRF membranes produced at high g-forces follows a gradient.
If we relate our findings to those observed with liquid PRF produced at 700 g for 8 min, the PPP
fraction provokes less activation of IL11 and NOX4 genes compared to the respective buffy coat
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layer [25]. We now show that with solid PRF produced at 650 g for 12 min, the PPP fraction provoked
less activation of IL11 and NOX4 genes than the respective buffy coat layer. We can thus conclude that in
liquid but also in solid PRF protocols using a horizontal centrifuge, the TGF-β activity follows a gradient.
Solid PPP produced at 1500 g for 12 min is even almost devoid of TGF-β activity. This observation
was originally surprising as we hypothesized that platelets would rapidly aggregate on polymerizing
fibrin and the TGF-β activity is retained in the PPP even at 1500 g [28]. Nevertheless, in clot activator
blood collection tubes, there is a gradient of TGF-β activity being high in the BC but almost null in the
PPP fraction produced with high-speed centrifugation.
It is noteworthy to translate our findings obtained with horizontal centrifuges to those observed
with fixed-angle centrifuges when preparing solid PRF. Fibrin polymerization is triggered by the contact
between coagulation factor XII and a procoagulation glass surface; thus, in fixed-angle centrifuges,
platelets are pressed to and accumulate on the distal side of the tube [8]. Likewise, in fixed-angle
centrifuges, TGF-β1 is relatively evenly distributed within the PRF matrix from the upper PPP
layer down to the BC layer [24]. This distribution along the back walls produced using fixed-angle
centrifuges can be explained by TGF-β1 being rapidly released from platelets hitting the distal wall [19],
and being then adsorbed by fibrin (ogen) [20], fibronectin [21] and vitronectin [22] of the blood clot [23].
The distribution of TGF-β in solid PRF produced by horizontal and fixed-angle centrifuges might thus
be different.
We can speculate that at high-speed protocols, platelets accumulate in the buffy coat fraction where
they release the content of their granules, including TGF-β that adsorbs to the fibrin-rich extracellular
matrix. This concept is supported by the general observation that TGF-β1 is released over days from
solid PRF membranes [9,10] that undergo spontaneous fibrinolysis. TGF-β being released within days
can theoretically originate from the platelets or leucocytes that continue producing TGF-β; this theory
is unlikely as platelets have no nucleus, so they cannot produce TGF-β like megakaryocytes [29].
Monocytes and neutrophils can produce TGF-β [30] but monocytes have to be activated and neutrophils
have a limited life span; thus, both cell types are not privileged to release considerable amounts of
TGF-β over days. It is presumably the intrinsic activation of fibrinolysis that causes the release of
TGF-β from PRF membranes.
Fibrinolysis of PRF clots can be activated by the microbiome, including Staphylococcus aureus,
Streptococcus pyogenes and Candida albicans [31,32]. The periodontal pathogen Porphyromonas gingivalis
also supports fibrinolysis [33]. Practically, however, the PRF membranes are produced ex vivo, avoiding
bacteria and fungi. Thus, the PRF membrane is probably protected from the fibrinolytic activity of the
microbiome, and the PRF membrane even possesses antibacterial effects, at least for P. gingivalis [34].
To simulate fibrinolysis, though, we have digested the PPP membranes with plasmin. PPP lysates failed
to enhance the expression of IL11 and NOX4 in fibroblasts. Thus, assuming that TGF-β theoretically
remains bound to PPP, it is not liberated by plasmin-mediated fibrinolysis. Future studies should
reveal if PPP holds back any TGF-β activity and how cells immigrating in PRF membranes can liberate
the TGF-β from the extracellular matrix [20–22].
The present study has a number of limitations. First, regarding the debates on the impact of cell
distribution on the activity of different parts of PRF, we only considered PRF prepared at 1500 g and
650 g. This exclusion was because the membrane from PRF prepared at 210 g was not big enough to be
sliced into two considerable parts and studied. Second, the screening for target genes is based on a
selection of two marker genes which are upregulated upon TGF-β receptor activation, mainly based
on our previous research with PRF [10] and acid bone lysates [35]. Therefore, other genes that are
responsive to growth factors other than TGF-β might have been oversighted. Furthermore, gingival
fibroblasts represent one out of many possible target cells for PRF and it is likely that the beneficial
effect of PRF in vivo requires the crosstalk between multiple cell types. The robust TGF-β activation
might only be relevant for mesenchymal cells while other cell types require the activation by other
components apart from growth factors.
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Considering these limitations, we can nevertheless conclude that the TGF-β activity,
when normalized to the size of the PRF membranes, is rather equal among the three protocols
produced using horizontal centrifugation. Since the size of the PRF membrane increases with speed,
the total TGF-β also increases at high-speed centrifugation. We further have to conclude that in
horizontal centrifuges, speed affects the distribution of TGF-β in the PRF clot, with almost no TGF-β
activity in the PPP fraction.
4. Materials and Methods
4.1. Cell Culture
Human gingiva was harvested from extracted wisdom teeth from patients who had given informed
and written consent. An approval was obtained from the Ethics Committee of the Medical University
of Vienna (EK NR 631/2007). A total of three strains of fibroblasts were established by explant cultures
and fewer than 10 passages were used for the experiments. Gingival fibroblasts were grown and
supplemented with 1% antibiotics (Sigma-Aldrich, St. Louis, MO, USA.) and 10% fetal calf serum
(Bio&Sell GmbH, Nuremberg, Germany). The cells were seeded at 30,000 cells/cm2 onto culture dishes
one day prior to stimulation. Cells were exposed to 30% lysates of PRF prepared at 210 g, 650 g and
1500 g for another 24 h under standard conditions at 37 ◦C, 5% CO2 and 95% humidity. To examine the
influence of TGF-β signaling, the inhibitor of TGF-β receptor type I kinase, SB431542 (Calbiochem,
Merck, Billerica, MA, USA), was used at 10µM.
4.2. Preparation of PRF Lysates
PRF was prepared after the approval of the Ethics Committee of the Medical University of Vienna
(1644/2018) and volunteers signed informed consent. All experiments were performed in accordance
with relevant guidelines and regulations. For preparation of PRF lysates, venous blood was collected
at the University Clinic of Dentistry from six healthy volunteers in glass-coated tubes (BD vacutainer,
BD368045, Plymouth, UK) and centrifuged at 210 g, 650 g (Figure 9) and 1500 g for 12 min (Z 306,
Hermle, Universal Centrifuge, Wehingen, Germany) with universal swing-out rotors (146 mm at the
max). The PRF clot was separated from the remaining red thrombus and compressed between two
layers of dry gauze. Each PRF membrane was transferred into serum-free medium (1 cm PRF/mL)
and exposed to two cycles of freeze-thawing and sonication (Sonopuls 2000.2, BANDELIN electronic,
Berlin, Germany). The lysate was subjected to centrifugation at 15,000 g for 10 min and the respective
supernatant was filtered sterile and stored at −20 ◦C before the in vitro analysis [36–38]. Exclusively,
PRF membrane prepared at 1500 g and 650 g (Figure 9) were also cut into two pieces closed to the border
(buffy coat; BC) and in the most upper part (platelet-poor plasma; PPP) of the membranes. For indicated
experiments, the 1500 g PPP membrane was incubated with 5 nM plasmin (Sigma-Aldrich, St. Louis,
MO, USA.) in Tris-HCl 50 mM (pH = 7.4) [39]. Following fibrinolysis at 37 ◦C for 4 h, the reaction was
terminated by heating at 65 ◦C for 15 min before centrifugation and sterile filtration was performed.
4.3. RT-qPCR Analysis and Immunoassay
For reverse transcription quantitative real-time PCR (RT-qPCR), total RNA was isolated with the
ExtractMe total RNA kit (Blirt S.A., Gdańsk, Poland). Reverse transcription was performed with cDNA
synthesis kit (LabQ, Labconsulting, Vienna, Austria). Polymerase chain reaction was performed with
the RT-PCR Kit (LabQ, Labconsulting, Vienna, Austria). Intron-spanning primers were designed based
on the algorithm of the Universal ProbeLibrary Assay Design Center (www.lifescience.roche.com) and
primer sequences were hGAPDH-F: aag cca cat cgc tca gac ac; hGAPDH-R: gcc caa tac gac caa atc c.;
hNOX4a-F tct tgg ctt acc tcc gag ga; hNOX4a-R: ctc ctg gtt ctc ctg ctt gg and hIL11 (qHsaCEP0049951;
Bio-Rad Laboratories, Inc., Hercules, CA). Amplification was monitored on the CFX ConnectTM
Real-Time PCR Detection System (Bio-Rad Laboratories, CA, USA). The mRNA levels were calculated
by normalizing to the housekeeping gene GAPDH using the ∆∆Ct method. The immunoassay for
Int. J. Mol. Sci. 2020, 21, 7629 9 of 12
human IL11 (DY218, R&D Systems, Minneapolis, MN, USA) was performed with the supernatant of
gingival fibroblasts exposed to PRF lysates at different g-forces after 24 h.
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Figure 9. PRF prepared at 650 g in a horizontal centrifuge. The yellow PRF clot was compressed between
two layers of dry gauze. Either the total PRF membrane or the PRF membrane being cut into two pieces
representing the buffy coat (BC) and the platelet-poor plasma (PPP) was used to prepare the lysates.
4.4. Immunofluorescence
The immunofluorescent analysis of Smad2/3 was performed in gingival fibroblasts plated onto
Millicell® EZ slides (Merck KGaA, Darmstadt, Germany) at 15,000 cells/cm2. Cells were exposed
to 30% of PRF prepared at 210 g, 650 g and 1500 g overnight. In indicated experiments, cells were
exposed to 30% of BC and PPP fractions of PRF prepared at 650 g and 1500 g. The cells were fixed with
4% paraformaldehyde, blocked with 1% bovine serum albumin and permeabilized with 0.3% Triton.
We used rabbit anti-Smad2/3 antibody (D7G7 XP®) at 4 ◦C overnight. Detection was with the goat
anti-rabbit Alexa 488 secondary antibody (CS-4412, 1:1000, Cell Signaling Technology). Images were
captured under a fluorescent microscope with a single filter block 455 nm (Oxion fluorescence, Euromex,
Arnheim, The Netherlands).
4.5. Western Blot
Gingival fibroblasts were seeded at 30,000 cells/cm2 into 6-well plates. The following day, the
medium was changed to serum-free for 8 h following stimulation for 16 h with 30% of PRF lysates
prepared at 210 g, 650 g and 1500 g or the PPP and BC fractions prepared at 650 g and 1500 g.
Extracts containing SDS buffer with protease and phosphatase inhibitors (cOmplete ULTRA Tablets
and PhosSTOP; Roche, Mannheim, Germany) were separated by SDS-PAGE and transferred onto
nitrocellulose membranes (Whatman, GE Healthcare, General Electric Company, Fairfield, CT, USA).
Membranes were blocked, and the binding of the first antibody rabbit phospho S423 + S425 (p-Smad3)
antibody (EP823Y, Abcam, Cambridge, UK) was detected with the second antibody labeled with HRP
(CS-7074, anti-rabbit IgG, 1:10,000, Cell Signaling Technology), respectively. After exposure to the
Clarity Western ECL Substrate (Bio-Rad Laboratories, Inc., Hercules, CA, USA) chemiluminescence
signals were visualized with the ChemiDoc imaging system (Bio-Rad Laboratories).
4.6. Statistical Analysis
All experiments were performed three to five times. Bars show the mean and standard deviation
of the cumulative data from the means of independent experiments. Statistical analysis of the IL11
and NOX4 expression and immunoassay was performed with ANOVA and post-hoc Fischer’s LSD
test for multiple comparisons. An ANOVA and post-hoc Fischer’s LSD test for multiple comparisons
compared all groups with each other. Analyses were performed using Prism v8 (GraphPad Software,
La Jolla, CA, USA). Significance was set at p < 0.05.
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